MannKind to Present at the Jefferies Global Healthcare Conference

Core Viewpoint - MannKind Corporation is set to present updates at the Jefferies London Healthcare Conference on November 19, 2025, highlighting its focus on innovative solutions for chronic diseases [1]. Company Overview - MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions [3]. - The company focuses on cardiometabolic and orphan lung diseases, developing treatments for serious unmet medical needs such as diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease [3]. Product Development Focus - MannKind specializes in drug-device combinations, aiming to deliver therapies that integrate seamlessly into patients' daily lives [4].